Utah Medical Products files Q2 2024 earnings release; detailed results not provided in filing text

UTAH MEDICAL PRODUCTS INC

2024-Q2 EPS reported $2.07 revenue$21,740,000

Company furnished financial information for three and six months ended June 30, 2024 via press release dated July 25, 2024.
Exhibit 99.1 referenced but actual financial data is missing from the provided filing text.
Forward-looking statements for 2024 and beyond are also included per the exhibit description.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.